Ukr.Biochem.J. 2013; Volume 85, Issue 2, Mar-Apr, pp. 45-51


Organ-specific antitoxic effects of N-stearoilethanolamine male mice with lewis carcinoma under indoxorubicin intoxication

E. A. Goudz, N. M. Gulа, T. N. Goridko, Y. N. Bashta, A. I. Voyeikov

Palladin Institute of Biochemistry,
National Academy of Sciences of Ukraine, Kyiv;

With the introduction of doxorubicin into mice with Lewis carcinoma in the heart and liver tissues and kidney the organ-antitoxic effects of N-stearoilethanolamine (NSE) were found, which depended on its concentration. Administration of doxorubicin to male mice leads to an increase in the level of urea and creatinine, as well as activation of ALT in blood plasma. Introduction of NSE resulted in normalization of these parameters to the level of intact animals. In the heart tissue  doxorubicin has multi-directional effects on the activity of antioxidant enzymes, in particular it decreases the activity of catalase and superoxide dismutase activity increases. Introduction of NSE normalizes these two indicators. It was found that tumor growth leads to an increase in the activity of glutathione peroxidase and superoxide dismutase. Introduction of NSE normalizes activity of these enzymes. Doxorubicin causes an increase in catalase activity in the kidney of mice with tumour, NSE prevented the increase in the activity of the above enzyme. The cancer process leads to increased levels of catalase activity in the liver of tumour-bearing mice, the introduction of NSE decreases the enzyme activity.

Keywords: , , , , , ,


  1. Wang WC, Uen YH, Chang ML, Cheah KP, Li JS, Yu WY, Lee KC, Choy CS, Hu CM. Protective effect of guggulsterone against cardiomyocyte injury induced by doxorubicin in vitro. BMC Complement Altern Med. 2012 Aug 27;12:138. PubMed, PubMedCentralCrossRef
  2. Swamy AV, Gulliaya S, Thippeswamy A, Koti BC, Manjula DV. Cardioprotective effect of curcumin against doxorubicin-induced myocardial toxicity in albino rats. Indian J Pharmacol. 2012 Jan;44(1):73-7. PubMed, PubMedCentral, CrossRef
  3. Elbl L, Hrstkova H, Tomaskova I, Michalek J. Late anthracycline cardiotoxicity protection by dexrazoxane (ICRF-187) in pediatric patients: echocardiographic follow-up. Support Care Cancer. 2006 Feb;14(2):128-36. PubMed, CrossRef
  4. Wouters KA, Kremer LC, Miller TL, Herman EH, Lipshultz SE. Protecting against anthracycline-induced myocardial damage: a review of the most promising strategies. Br J Haematol. 2005 Dec;131(5):561-78. Review. PubMed, CrossRef
  5. Shah SL, Mali VR, Zambare GN, Bodhankar SL. Cardioprotective Activity of Methanol Extract of fruit of Trichosanthes cucumerina on Doxorubicin-induced Cardiotoxicity in Wistar Rats. Toxicol Int. 2012 May;19(2):167-72. PubMed, PubMedCentral, CrossRef
  6. Anisimov AA. Medical enzymology. Gorky, 1978. 150 p.
  7. Ahmed F, Urooj A. Cardioprotective activity of standardized extract of Ficus racemosa stem bark against doxorubicin-induced toxicity. Pharm Biol. 2012 Apr;50(4):468-73.  PubMed, CrossRef
  8. Kintzel PE. Anticancer drug-induced kidney disorders. Drug Saf. 2001 Jan;24(1):19-38. Review. PubMed
  9. Reinhold SW, Reichle A, Leiminger S, Bergler T, Hoffmann U, Krüger B, Banas B, Krämer BK. Renal function during rofecoxib therapy in patients with metastatic cancer: retrospective analysis of a prospective phase II trial. BMC Res Notes. 2011 Jan 5;4:2. PubMed, PubMedCentral, CrossRef
  10. Francescato HD, Marin EC, Cunha Fde Q, Costa RS, Silva CG, Coimbra TM. Role of endogenous hydrogen sulfide on renal damage induced by adriamycin injection. Arch Toxicol. 2011 Dec;85(12):1597-606. PubMed, CrossRef
  11. Ottria R, Casati S, Ciuffreda P. Optimized synthesis and characterization of N-acylethanolamines and O-acylethanolamines, important family of lipid-signalling molecules. Chem Phys Lipids. 2012 Oct;165(7):705-11. PubMed, CrossRef
  12. Contassot E, Wilmotte R, Tenan M, Belkouch MC, Schnüriger V, de Tribolet N, Burkhardt K, Dietrich PY. Arachidonylethanolamide induces apoptosis of human glioma cells through vanilloid receptor-1. J Neuropathol Exp Neurol. 2004 Sep;63(9):956-63. PubMed
  13. Contassot E, Tenan M, Schnüriger V, Pelte MF, Dietrich PY. Arachidonyl ethanolamide induces apoptosis of uterine cervix cancer cells via aberrantly expressed vanilloid receptor-1. Gynecol Oncol. 2004 Apr;93(1):182-8. PubMed, CrossRef
  14. Mimeault M, Pommery N, Wattez N, Bailly C, Hénichart JP. Anti-proliferative and apoptotic effects of anandamide in human prostatic cancer cell lines: implication of epidermal growth factor receptor down-regulation and ceramide production. Prostate. 2003 Jun 15;56(1):1-12. PubMed, CrossRef
  15. McKallip RJ, Lombard C, Fisher M, Martin BR, Ryu S, Grant S, Nagarkatti PS, Nagarkatti M. Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease. Blood. 2002 Jul 15;100(2):627-34. PubMed, CrossRef
  16. Parolaro D, Massi P, Rubino T, Monti E. Endocannabinoids in the immune system and cancer. Prostaglandins Leukot Essent Fatty Acids. 2002 Feb-Mar;66(2-3):319-32. Review. PubMed, CrossRef
  17. Bifulco M, Laezza C, Valenti M, Ligresti A, Portella G, DI Marzo V. A new strategy to block tumor growth by inhibiting endocannabinoid inactivation. FASEB J. 2004 Oct;18(13):1606-8. PubMed, CrossRef
  18. Khasabova IA, Khasabov S, Paz J, Harding-Rose C, Simone DA, Seybold VS. Cannabinoid type-1 receptor reduces pain and neurotoxicity produced by chemotherapy. J Neurosci. 2012 May 16;32(20):7091-101. PubMedPubMedCentralCrossRef
  19. Hula NM, Khmel’ TO, Klimashevsky VM, Kulik HI, Todor IM. N-stearoylethanolamine inhibits growth and metastasis of the Lewis carcinoma and modulates lipid composition of the lung during tumorogenesis in mice. Ukr Biokhim Zhurn. 2006 Jan-Feb;78(1):135-42. Ukrainian. PubMed
  20. Gulaya NM, Smirnov IM, Shmal’ko IuP, Mel’nik AA, Mel’nik SN. Effect of N-palmitoyl- and N-stearoylethanolamines on lipid peroxidation in mouse tissues in metastatic Lewis carcinoma. Ukr Biokhim Zhurn. 1993 Nov-Dec;65(6):96-101. Russian. PubMed
  21. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265-75. PubMed
  22. Koroliuk MA, Ivanova LI, Mayorova IG, Tokarev VE. A method of determining catalase activity. Lab Delo. 1988;(1):16-9. Russian. PubMed
  23. Csóvári S, Andyal T, Strenger J. Determination of the antioxidant properties of the blood and their diagnostic significance in the elderly. Lab Delo. 1991;(10):9-13. Russian.  PubMed
  24. Pereslegina IA. The activity of antioxidant enzymes in the saliva of normal children. Lab Delo. 1989;(11):20-3. Russian. PubMed
  25. Tits  NA. Encyclopedia of clinical laboratory tests. 1997. P. 277-178.
  26. Deavall DG, Martin EA, Horner JM, Roberts R. Drug-induced oxidative stress and toxicity. J Toxicol. 2012;2012:645460. PubMed, PubMedCentral, CrossRef

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License.